docosahexaenoic acid ethyl ester

Docosahexaenoic acid ethyl ester is the ethyl ester prodrug and pharmaceutical form of **docosahexaenoic acid**, a long-chain omega-3 fatty acid used in lipid-lowering formulations for severe hypertriglyceridemia. After oral administration it is hydrolyzed to docosahexaenoic acid, incorporated into plasma and tissue lipids, and is thought to lower hepatic very low-density lipoprotein triglyceride synthesis while promoting triglyceride clearance, producing reductions in circulating triglycerides. It is not a distinct receptor-targeted small molecule in the usual oncology or CNS sense, but rather a highly purified omega-3 lipid derivative used as an active pharmaceutical ingredient or formulation component in prescription omega-3 products and related lipid-modifying preparations.

Other names

docosahexaenoic acid ethyl esterethyl docosahexaenoateDHA ethyl esterdocosahexaenoic acid ethylester